4//SEC Filing
BENNETT C FRANK 4
Accession 0000874015-25-000178
CIK 0000874015other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:14 PM ET
Size
8.8 KB
Accession
0000874015-25-000178
Insider Transaction Report
Form 4
BENNETT C FRANK
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-08-18$43.98/sh−10,000$439,776→ 93,466 total - Exercise/Conversion
Common Stock
2025-08-18$32.60/sh+10,000$326,000→ 103,466 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-08-18−10,000→ 18,869 totalExercise: $32.60From: 2023-01-03Exp: 2032-01-02→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 13, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $44.25 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001073387
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 6:14 PM ET
- Size
- 8.8 KB